Company Information Sheet Page: 1

FORMS RELATING TO LISTING

Form F

The Growth Enterprise Market (GEM)

Company Information Sheet



Company name : New Chinese Medicine Holdings Limited
新醫藥控股有限公司

Stock code (ordinary shares): 8085

This information sheet contains certain particulars concerning the above company (the "Company") which is
listed on the Growth Enterprise Market ("GEM") of the Stock Exchange of Hong Kong Limited (the
"Exchange"). These particulars are provided for the purpose of giving information to the public with regard to
the Company in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market
of They will be displayed at the GEM
website on the Internet. This information sheet does not purport to be a complete summary of information
relevant to the Company and/or its securities.

The information in this sheet was updated as of 21 January 2008.

A. General

Place of incorporation : The Cayman Islands

Date of initial listing on GEM : 7 March, 2002

Name of Sponsor(s) : N/A

Names of directors : Executive Directors:
(please distinguish the status of the directors - Mr. Liu Jing
Executive, Non-Executive or Independent Mr. Chu Hon Pong
Non-Executive) Mr. Li Heguo
Mr. An Jinping
Mr. Li Junhong
Ms. Tong Pui Chi Lucia
Mr. Law Kwok Chung

Non-executive Directors:
Dr. Neil Kai Gu

Independent Non-executive Directors:
Mr. Chu Kar Wing
Dr. Loke Hoi Lam
Mr. Ku Ling Yu John

Company Information Sheet Page: 2
Name(s) of substantial shareholder(s) (as such term is defined in rule 1.01 of the GEM Listing Rules) and their
respective interests in the ordinary shares and other securities of the Company:

Approximate
Number percentage of
Name of Shares held shareholding

Excel Point Holdings Limited 354,980,000 33.72%
Mr. Chu Hon Pong 156,150,967 14.83%
Mr. Mo Shikang (“Mr. Mo”, Note) 150,000,000 14.25%
Asian Allied Limited (“Asian Allied”, Note) 150,000,000 14.25%
Super Win Development Limited (“Super Win”, Note) 150,000,000 14.25%
Chinese People Holdings Company Limited (“CPH”, Note) 150,000,000 14.25%

Note:

As CPH is a subsidiary of Super Win, Super Win is deemed to have interest in the ordinary shares of the
Company (“the Shares”) held by CPH for the purpose of the Securities and Future Ordinance (“SFO”). For the
purpose of the SFO, Asian Allied is deemed to have interest in the Shares held by Super Win and Mr. Mo is
deemed to have interest in the Shares held by Asian Allied.

Name(s) of company(ies) listed on GEM : N/A
or the Main Board of the Stock Exchange
within the same group as the Company

Financial year end date : 31 March

Registered address : Cricket Square
Hutchins Drive
P.O. Box 2681
Grand Cayman KY1-1111
Cayman Islands
British West Indies

Head office and principal : Room 802, Tower 1
place of business Harbour Centre
1 Hok Cheung Street
Hunghom
Kowloon
Hong Kong

Web-site address (if applicable) : www.ncm.com.hk

Share registrar : Principal share registrar:
Butterfield Fund Services (Cayman) Ltd.
Butterfield House
68 Fort Street
P.O. Box 705
George Town
Grand Cayman
Cayman Islands
British West Indies

Hong Kong branch share registrar:
Tricor Standard Limited
26/F, Tesbury Centre,
28 Queen’s Road East,
Hong Kong

Auditors : HLB Hodgson Impey Cheng
Certified Public Accountants



Company Information Sheet Page: 3
B. Business activities

The mission of the Group is to modernise traditional Chinese medicine and promote the use of modernised Chinese
medicine and health care products to international markets. The Group is principally engaged in the marketing and
distribution of health care products.

C. Ordinary shares

Number of ordinary : 1,052,738,882
shares in issue

Par value of ordinary shares in issue : HK$0.04 per share

Board lot size (in number of shares) : 20,000

Name of other stock exchange(s) on which : N/A
ordinary shares are also listed

D. Warrants

Stock code : 8359

Board lot size : 20,000

Expiry date : 30 June 2010

Exercise price : HK$0.46

Conversion ratio : N/A
(Not applicable if the warrant is
denominated in dollar value of
conversion right)

No. of warrants outstanding : 149,967,778

No. of shares falling to be issued : 195,610,145
upon the exercise of outstanding
warrants

E. Other securities

Share Option

Number of share options granted
And outstanding : 105,219,106

Company Information Sheet Page: 4
Responsibility statement

The directors of the Company (the "Directors") as at the date hereof hereby collectively and individually accept
full responsibility for the accuracy of the information contained in this information sheet ("the Information") and
confirm, having made all reasonable inquiries, that to the best of their knowledge and belief the Information is
accurate and complete in all material respects and not misleading and that there are no other matters the omission
of which would make any Information inaccurate or misleading.

The Directors also collectively and individually accept full responsibility for submitting a revised information
sheet, as soon as reasonably practicable after any particulars on the form previously published cease to be
accurate.

The Directors acknowledge that the Stock Exchange has no responsibility whatsoever with regard to the
Information and undertake to indemnify the Exchange against all liability incurred and all losses suffered by the
Exchange in connection with or relating to the Information.
Signed:


___________________________ ___________________________
Mr. Liu Jing Mr. Chu Hon Pong

___________________________ ___________________________
Mr. Li Heguo Mr. An Jinping

___________________________ ___________________________
Mr. Li Junhong Ms. Tong Pui Chi Lucia

___________________________ ___________________________
Mr. Law Kwok Chung Dr. Neil Kai Gu

___________________________ ___________________________
Mr. Chu Kar Wing Dr. Loke Hoi Lam

___________________________
Mr. Ku Ling Yu John